AKT1 and cancer: The mechanism of naringenin against COVID-19/LUSC is strongly linked to oxidative stress, immunoregulation, apoptosis, antiviral, anti-inflammatory, anti-cancer, and related pathways including PI3K-Akt, HIF-1, and VEGF signaling pathway, according to the findings of GO and KEGG enrichment study.